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ABSTRACT 
Objective: The objective of this research was to formulate and evaluate anti-acne ointment of C-phycocyanin(C-PC) extracted from spirulina. 
Methods: C-PC was successfully extracted from spirulina by using sonication and cold-maceration process and further purified by dialysis method. 
By employing disc diffusion and agar dilution method, antimicrobial activity and minimum inhibitory concentration(MIC) of C-PC as determined 
against Propionibacterium acne (P. acne) and Staphylococcus epidermidis(S. epidermidis). Further, the two different formulations were prepared by 
using water soluble and oleaginous bases, and the formulations were characterized for particle size, viscosity, pH, consistency, drug diffusion, 
antimicrobial activity, and antioxidant effect and stability studies.  
Results: C-PC showed MIC value of 1.5±0.1 mg/ml and 1.8±0.2 mg/ml against P. acne and S. epidermidis respectively. The developed formulation 
had a globule diameter of 5.44 mm, pH of 6.8±0.09, the viscosity of 175±0.2cps, spreadability of an 8.6±0.12g. cm/sec and had good consistency. 
Both formulations were found stable among which, formulation B(FB) had maximum drug content of 95±0.6% and drug release was up to 92±0.8%. 
Conclusion: The prepared topical C-PC ointment can be successfully employed in the treatment of acneagainstP. acne and S. epidermidis. 
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Acne is a long-term skin disease that arises when hair sacs are blocked 
with departed skin cells [1]. It is categorized by spots, blackheads, 
whiteheads, redness, inflammations or oily skin [2, 4]. It can be of the 
inflammatory and non-inflammatory type of acne. Non-inflammatory 
includes blackheads, whiteheads while inflammatory includes pimples 
that are red and swollen. Skin areas with comparatively higher in oil 
glands such as the face, superior part of the upper body, and posterior 
majorly affected [5]. The subsequent presence may lead to nervousness, 
reduced confidence and downheartedness [6, 7]. Genetics and increased 
sex hormones during adolescence in both the genders are the primary 
causes of acne in 78% of cases [3, 10]. However, the role of food and 
smoking is still unclear [8, 9]. P. acne and S. epidermidisare the two 
major gram-+ve bacterial species responsible for acne vulgaris. The 
former one is an anaerobic, rod-shaped bacteria which lives at the base 
of the hair follicle breaks down sebum to consume as food, as bacteria 
increases, it causes inflammation which results in an immune response. 
Whereas the later induces acne together with other skin bacteria. 
Spirulina is a microscopic filamentous marine cyanobacterium of 
genus spirulina, especially Arthrospiraplatensis that is used as a dietary 
supplement which consists of 70% protein by weight [11]. Of these 
proteins, the phycobiliproteins (antenna-like proteins involved in light 
harvesting) named allophycocyanin, C-PC and phycoerythrin. C-PC is a 
holoprotein and also known as phycobiliproteins [12, 14]. It is 
responsible for most of the natural benefits being delivered by 
spirulina. C-PC and β-carotene that have potent antioxidant, 
antimicrobial and anti-inflammatory activities, exerts strong free 
radical scavenging activity, inhibits pro-inflammatory cytokine 
formation, such as TNFα, suppresses cyclooxygenase-2 (COX-2) 
expression and decreases prostaglandin E2 production [13]. Due to 
increased instances of resistance of acne-inducing bacteria towards 
the synthetic drugs, the alternate system of medicine for the treatment 
of acne have been investigated and adopted. Among the alternate 
systems of medicine, the topical therapeutic agents are more 
convenient for application. Topical acne treatment is occupying the 
upper position as they are safe, dilute, patient familiar, economical, 
easily available and multifunctional. Hence spirulina is natural and 
possessing both anti-inflammatory and antioxidant properties, the 
present study aims to explore its application in the treatment of acne 
and also evaluate the antimicrobial property of the spirulina 
containing C-PC against acne-causing species. 
MATERIALS AND METHODS 
Spirulina was procured from Genius natural herbs Pvt. Ltd. 
Coimbatore, India. Paraffin hard, cetostearyl alcohol and liquid 
paraffin are obtained from Loba Chemie. Pvt. Ltd, Mumbai. Wool fat 
and white soft paraffin were procured from Rajesh chemi. Pvt. Ltd, 
Mumbai. PEG400, PEG4000, ammonium sulfate and stearyl alcohol 
were procured from Merckspecialties. pvt, Ltd. Mumbai. The sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
the molecular indicator was procured from genei Pvt Ltd Bangalore. 
P. acne and S. epidermidis were procured from NCL, Pune. 
Extraction of protein 
Cold maceration and sonication are two methods used for isolation of C-
PC. In cold maceration process 1:25(w/v) spirulina dry powder: water at 
40 °C for 24 h. In the sonication process, 1:25 (w/v) of Spirulina dry 
powder in H2
Purification 
O was sonicated at 40 kHz for 45 min. The semi-liquid 
mixture obtained was subjected for centrifugation at 1000rpm for 20 
min at 4 °C. The precipitate (ppt) was discarded and the supernatant 
layer was collected. The pH was set to pH 7.0 for subsequent stages [17]. 
(NH4)2SO4
To attain 50% saturation, (NH
 precipitation 
4
Dialysis and gel filtration 
)2SO4 solution was added to 100 ml 
extract with non-stop stirring. The solution was thenkeptside for 120 
min. Later was centrifuged at 1200rpm for 30 min. The blue ppt found 
was liquefied in 0.005 M Sodium-phosphate buffer (pH-7.0)[17]. The 
concentration was calculated by Boussiba and Richmond method [16] 
and purity by Bennett and Bogorad method [15]. 
The solution was dialyzed overnight at 4 °C counter to one liter of 
0.005 M sodium phosphate buffer (pH-7.0). The obtained solution 
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was filtered by fleeting over a Sephadex G-25 column (12 × 2 cm). 
Elements were collected at a flow rate of 0.5 ml/min [17]. 
Electrophoresis in polyacrylamide gel 
In a vertical chamber using 12% SDSPAGE [19]. The sample 
obtained after dialysis was subjected to electrophoresis and gel 
filtration. Molecular indicators were a protein marker wide range, 
(Myosin 205 kDa, Phosphorylase B 97.4 kDa Bovine serum albumin 
66 kDa, Ovalbumin 43 kDa, Carbonic anhydrase 29 kDa, Soybean 
trypsin inhibitor 20.1 kDa, Lysozyme 14.3 kDa, Aprotinin 6.5 kDa, 
Insulin 3.5 kDa.) The gel was marked by 0.1% Coomassie Brilliant 
G250 solution after electrophoresis [18]. 
Antioxidant activity of C-phycocyanin 
Determination of the activity of C-PC-from spirulina sample was 
done by electron spin resonance (ESR) spectroscopy [20]. The ESR 
spectrometer Bruker 300E registers all ESR spectra. The 
antioxidant activity of C-PC was found in the concentration range 
of 0.05–0.3 mg ml−1. 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
artificial constant was taken as standard. The enactment of ESR 
quantities was held in the following conditions: field modulation 
100 kHz, modulation amplitude 0.256 G, receiver gain 2×104, the 
time constant 40.96 m, conversion time 327.68 m, centre field 
3440.00 G, sweep width 100.00 G, x-band frequency 9.45 GHz, 
power 7.96 mW, at 25 °C. The antioxidant activity of C-PC was 
defined as: AADPPH = 100 × (h o  − h x)/h o  [%], In the ESR spectrum 
of DPPH radicals of the blank and probe, h o  and hx  are the height 
of the 2nd
Preparation of the ointment 
 peak respectively. 
Two formulations FA and FB consisting of oileogenous base and 
water base respectively were prepared (table 1 and 2). 
  
Table 1: Formulation chart of oleaginous base 
Ingredients  Quantity in % 
Paraffin hard  5 
Wool fat  10 
Cetostearyl alcohol  10 
White soft paraffin  50 
 Liquid paraffin  15 
Extract(C-PC)  10 
 
Ointment base was prepared by adding cetostearylalcohol and wool 
fat in melted hard paraffin. Finally, white soft paraffin was added 
and mixed thoroughly on heating mantle and kept aside. Other 
ingredients were weighed accordingly and added to the above 
mixture (step 1). 
A measured quantity of extract(C-PC) and liquid paraffin were 
poured into a motor pestle and stirred in one direction by adding the 
required quantity of the ointment base until a homogenous product 
is obtained. The prepared formulations were stored in ointment 
tubes for further studies. 
 
Table 2: Formulation chart of the water-soluble base 
Ingredients Quantity in % 
PEG400  12 
PEG4000  18 
Stearyl alcohol  28 
Extract 10 
Glycerine  17 
Water q. s 
 
The required quantity of the ingredients and extract were weighed 
and stirred thoroughly at a low temperature until the uniform base 
is formed. The volume was made up to the required quantity with 
water and stored in an ointment tube at room temperature until 
further studies were carried out. 
Evaluation test 
Physical parameters and identification test 
The preparation was mixed with water, and the odour was observed. 
By placing the formulation against white background colour was 
observed. By applying the formulation on the hand, greasiness was 
observed and identification was done visually by placing it in white 
background. 
Uniformity of weight % 
Randomly filled 20tubes were weighed. The tubes were emptied, 
washed with alcohol and dried. The weight of the empty tubes was 
measured using a digital weighing balance (Shimadzu digital 
weighing balance model no; BL220H). The difference between the 
weights was calculated as the net weight of the ointment tube. The 
average net weight of 20 tubes was noted [21]. 
Globule diameter 
With the help of projection microscope, SIPCON SP, 585. The average 
diameter was calculated. 
pH 
Digital pH meter ELICO LI120 (type 003) was employed. About 10g 
of the formulation was diluted and exposed to pH measurement. 
Loss on drying 
The ointment was taken in a dry Petri dish on a water bath and dried 
for 100 °C. Loss on drying was determined [21]. 





Between 2 glass slides 1g of, the ointment was placed and 100g of 
weight (m) was placed above the plates. The extra was scrapped off 
after removing the weight. Lesser the time is taken (t) is taken 
separation of the two slides, the better is the spreadability(S) [22]. 
S = m × (l ÷ t) 
Consistency or hardness of ointment 
Three samples were melted and filled into containers without air bubbles 
and sheared for 5 min then stored at 25±0.5 °C for 24 h. samples were 
tested using Penetrometer by adjusting the temperature at 25+0.5 °C and 
position was adjusted such that its tip just touches the surface of the 
sample and was released for 5 sec and penetration depth was measured 
and repeated with other samples [23]. 
Gowda et al. 
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Test of the rate of penetration 
The rate of penetration can be predictable with the help of flow-
through diffusion cell. Animal skin of certain known area should be 
removed and knotted to the receptacle existing in a flow-through 
diffusion cell and placed in a liquid bath. A known amount of the 
formulation is smeared on the skin, and the amount of drug 
penetrated into the fluid is measured by collecting aliquots at 
regular intervals and measured by using a spectrophotometer [24]. 
Test of content uniformity 
The gross weight of 10 formulation tubes was measured. The outcomes 
obtained should tie each other and with the considered amount. 
Viscosity of ointment 
The sample was taken in a dry 250 ml beaker, by using spindle nos. 
1 to 4. OF CAP-2000 Brookfield viscometer DV-2Ⅱ+
The antibacterial action of both the FA and FB consisting C-PC 
against P. acne and S. epidermidis were estimated by disc diffusion 
method and the zone of inhibition was measured with zone reader. 
By using an agar dilution method, MIC was measured. Nutrient agar 
media was used at 37 °C+2 °C for 2 d [26]. 
PRO (model no; 
LR99102) viscosity was determined [25]. 
Microbiological studies 
Diffusion study 
3 gm of the formulation was placed in the donor section of the 
modifiedkiescarychein diffusion cell, Electro lab diffusion cell 
(model no; EDC-07). The receptor section containing 22 ml of 
phosphate buffer pH 7.4 was in contact with the complete surface 
of the cellophane membrane. And magnetic stirrer was 
continuously stirred at 100rpm at temperature 37±0.5°C. 3.14 cm2 
Stability studies 
is the surface area of-of accessible for diffusion. The experiment 
was carried out by maintaining the sink condition for 5 h, and the 
sampling interval was 30 min. The content of C-PC was 
determined. 
Ointment tube were stored at altered temperature condition viz. 25 
°C±2 °C/60%RH±5℅RH, 30 °C+2 °C/65℅ RH+5℅RH, 40 °C+2 
°C/75℅ RH+5℅RH over 180days in a thermal humidity chamber, 
thermolabs, Mumbai and studied for various parameters of the 
formulations [27]. 
 
RESULTS AND DISCUSSION 
Table 3: Identification of ingredients in both FA ֶ◌and FB 
S. No. Identification  Specification 
1 Hard Paraffin  White Colour 
2 Wool Fat Light Yellow 
3 Cetostearyl Alcohol Color Less 
4 White Soft Paraffin White Color 
5 Peg 400 Color Less  
6 Peg 4000 Color Less 
7 Extract Intense Blue 
 
 
Fig. 1: Antioxidant activity of C-PC (n=3, mean±SD) 
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Table 4: Estimation of various parameters for anti-acne formulation 
Evaluation parameters  FA FB 




Uniformity of weight Obey with standard  Obey with standard 
Globule diameter  5.29 mm 5.44 mm 
pH  6.1±0.06 6.8±0.09 
Loss on drying 35℅w/w  47℅w/w 
 Consistency  Good Good 
Viscosity  198±0.4 cps  175±0.2 cps 




3, mean±SD, The consistency of FB was superior to FA. The FA was found to be more viscous (198±0.4cps) than FB (175±0.2cps). Thus the FB 
has better spreadability characters (8.6±0.12g. cm/sec) than FA (8.1±0.11g. cm./sec). 
C-PC showed 100% action at the concentration of 0.15 mg 
ml−1. Spirulina has the action which is analogous to that 
of Limnothrix. The (EC50) value of C-PC was about 0.08 mg 
ml−1 which is slightly greater, but equivalent to the activity of rutin 
at an EC50 value of 0.055 mg ml−1 
Antioxidative activity of C-PC. The bars designate the standard error 
of 3 dimensions. 
fig. 1. 
From the outcomes, it was found that FB diffusing 0.7 cm length after 
1hr whereas FA diffuses 0.5 cm after 1hr and In vitro drug diffusion for 
FB was found to be 92% after 5th 
 
hr and for FA it is 88 %. The results 
are shown in fig. 2. 
 
Fig. 2: Diffusion study of formulation A and B (n=3, mean±SD) 
 
The antimicrobial activity of anti-acne ointment in FA and FB were 
determined. The zones of inhibition of P. acne and S. epidermidis are 
described in table 5. Comparatively, FB was found to be superior to 
FA.
 
Table 5: Antimicrobial action of anti-acne ointment 
The diameter of zone of inhibition (mm) MIC * 
Formulation P. acne S. epidermidis P. acne S. epidermidis 
A 23.4±1.0 21.3±1.4 1.6±0.4 mg/ml 2.1±0.6 mg/ml 




Table 6: Stability parameters 
Parameters (after 3rd week) FA FB 
Temp 25˚ C 30˚C 40˚C 25˚C 30˚C 40˚C 
pH* 6.6±.01 6.6±.02 6.4±.01 6.8±.04 7.1±.03 7.3±.06 
Spreadability(g/sec)* 38.6±.2 36.8±.3 42.±.2 44.±.8 42.6±.5 42.±.9 
Consistency  165 163 161 203 202 203 
Globule diameter 4.13 5.11 5.14 5.26 5.34 5.24 
*n=3, mean±SD, from the above outcomes, it is evidently manifest that there were no fluctuations in the evaluation parameters of both the 
formulations. Comparatively, FB was found to be further acceptable than FA. 
Gowda et al. 




Antibiotics like tetracycline, salicylic acid etc. show resistance and 
side-effects, C-PC being natural would be comparatively safe for 
treating acne. Studies have stated that the aqueous coriander extract 
had MIC values of 1.7 mg/ml and 2.1 mg/ml, zone of inhibition of 
21.5±1.4 mm and 20.6±1.09 mm against P. acne and S. epidermidis 
respectively. Whereas in our present study, the aqueous extract of 
spirulina has MIC values of 1.5±0.1 mg/ml and 1.8±0.2 mg/ml, the 
zone of inhibition of 26.1±1.2 mm and 24.6±1.6 mm respectively. 
The results indicate that aqueous spirulina extract has better 
antimicrobial property than aqueous coriander extract [22]. 
CONCLUSION 
Based on the study results, it is concluded that the spirulina extract 
possesses anti-acne property. And formulation comprising water-
soluble base was superior to the oleaginous base, due to the 
complete solubility of the extract in water. 
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